COMPANY OVERVIEW

Imara Inc., is dedicated to developing novel therapeutics for people living with sickle cell disease and other hemoglobinopathies.

---

LOCATION

Cambridge, MA, USA

---

THERAPEUTIC AREAS

Hematology

Rare Diseases

---

WEBSITE

https://imaratx.com

---

CAREER WEBSITE

None

---

SOCIAL MEDIA

---

INVESTORS

---

---

PRESS RELEASES

Feb 6, 2020

Imara Appoints Joelle Lufkin, M.P.H., as Senior Vice President of Development

Sep 13, 2019

Imara Submits Confidential Draft Registration Statement for Proposed Initial Public Offering

Aug 13, 2019

Imara Expands Management Team and Strengthens Expertise Across Strategic Functions as it Advances IMR-687 for Sickle Cell Disease and Beta Thalassemia

Jun 18, 2019

Imara Presented Positive, Interim Phase 2a Data on IMR-687 for the Treatment of Sickle Cell Disease at the 24th Congress of the European Hematology Association

Jun 18, 2019

Arix Bioscience plc: Imara Presents initial Phase 2a data for IMR-687

For More Press Releases

---